Investor Relations

NASDAQ: SWKH
Stock Quote
NASDAQSWKH

About SWK Holdings

We are a specialized finance company with a specific focus on opportunities in the global healthcare sector. We provide innovative capital solutions to a broad range of life science companies, institutions and inventors.

We provide capital to our business partners through our own balance sheet as well as through our investment advisory clients, which include family offices and institutional investors. Our broad capital base positions us to be the partner of choice for life science entities looking for flexible, nontraditional sources of capital.

Our management team has extensive experience specifically in healthcare-related principal investing and structured finance, resulting in a deep understanding of business opportunities in the life science sector.

For our investors, we expect to provide superior risk-adjusted returns on capital by investing in marketed ethical product cash flow streams.

Latest News
Aug 23, 2021

Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation...

Aug 16, 2021

Corporate Updates The Specialty Finance Receivables and Pharmaceutical Development segments each reported strong quarters Closed a $5.0 million synthetic royalty transaction in April 2021 and a...

Jul 19, 2021

SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, today provided an...

View All Releases

Latest Presentation

Fall Investor Summit Webcast and Presentation
September 16, 2019

Listen to Webcast

Upcoming & Recent Events
Contact Us

Maureen McEnroe
Tiberend Strategic Advisors, Inc.
(212) 375-2664
mmcenroe@tiberend.com

Portfolio

To see news related to SWK Holdings' Portfolio, click here.

Latest Quarterly Results